rs540520

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000706469.1(SRSF9):​c.89+653C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.396 in 150,256 control chromosomes in the GnomAD database, including 14,131 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.40 ( 14131 hom., cov: 29)

Consequence

SRSF9
ENST00000706469.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.234

Publications

20 publications found
Variant links:
Genes affected
SRSF9 (HGNC:10791): (serine and arginine rich splicing factor 9) The protein encoded by this gene is a member of the serine/arginine (SR)-rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. Each of these factors contains an RNA recognition motif (RRM) for binding RNA and an RS domain for binding other proteins. The RS domain is rich in serine and arginine residues and facilitates interaction between different SR splicing factors. In addition to being critical for mRNA splicing, the SR proteins have also been shown to be involved in mRNA export from the nucleus and in translation. Two pseudogenes, one on chromosome 15 and the other on chromosome 21, have been found for this gene. [provided by RefSeq, Sep 2010]
DYNLL1 (HGNC:15476): (dynein light chain LC8-type 1) Cytoplasmic dyneins are large enzyme complexes with a molecular mass of about 1,200 kD. They contain two force-producing heads formed primarily from dynein heavy chains, and stalks linking the heads to a basal domain, which contains a varying number of accessory intermediate chains. The complex is involved in intracellular transport and motility. The protein described in this record is a light chain and exists as part of this complex but also physically interacts with and inhibits the activity of neuronal nitric oxide synthase. Binding of this protein destabilizes the neuronal nitric oxide synthase dimer, a conformation necessary for activity, and it may regulate numerous biologic processes through its effects on nitric oxide synthase activity. Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.679 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000706469.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DYNLL1
NM_001037494.2
c.-7+3879G>A
intron
N/ANP_001032583.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SRSF9
ENST00000706469.1
c.89+653C>T
intron
N/AENSP00000516402.1
DYNLL1
ENST00000392509.6
TSL:3
c.-7+3879G>A
intron
N/AENSP00000376297.2
DYNLL1
ENST00000548342.5
TSL:2
c.-144+3879G>A
intron
N/AENSP00000447907.1

Frequencies

GnomAD3 genomes
AF:
0.396
AC:
59454
AN:
150138
Hom.:
14096
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.686
Gnomad AMI
AF:
0.343
Gnomad AMR
AF:
0.291
Gnomad ASJ
AF:
0.434
Gnomad EAS
AF:
0.233
Gnomad SAS
AF:
0.285
Gnomad FIN
AF:
0.265
Gnomad MID
AF:
0.360
Gnomad NFE
AF:
0.283
Gnomad OTH
AF:
0.353
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.396
AC:
59538
AN:
150256
Hom.:
14131
Cov.:
29
AF XY:
0.392
AC XY:
28751
AN XY:
73262
show subpopulations
African (AFR)
AF:
0.686
AC:
28205
AN:
41116
American (AMR)
AF:
0.291
AC:
4368
AN:
15006
Ashkenazi Jewish (ASJ)
AF:
0.434
AC:
1501
AN:
3458
East Asian (EAS)
AF:
0.233
AC:
1149
AN:
4932
South Asian (SAS)
AF:
0.285
AC:
1344
AN:
4718
European-Finnish (FIN)
AF:
0.265
AC:
2736
AN:
10326
Middle Eastern (MID)
AF:
0.361
AC:
99
AN:
274
European-Non Finnish (NFE)
AF:
0.283
AC:
19098
AN:
67454
Other (OTH)
AF:
0.352
AC:
729
AN:
2070
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1539
3077
4616
6154
7693
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
538
1076
1614
2152
2690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.317
Hom.:
33171
Bravo
AF:
0.407
Asia WGS
AF:
0.302
AC:
1053
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.0
DANN
Benign
0.43
PhyloP100
-0.23
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs540520; hg19: chr12-120911786; API